Latest News about ALNY
Recent news which mentions ALNY
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
October 31, 2024
Tickers
ALNY
From Benzinga
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
October 23, 2024
From Benzinga
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
October 11, 2024
From Benzinga
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
October 06, 2024
From Benzinga
From Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,300 Today
September 30, 2024
From Benzinga
Looking Into Alnylam Pharmaceuticals's Recent Short Interest
September 26, 2024
Tickers
ALNY
From Benzinga
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 10 Years
September 11, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 02, 2024
From Benzinga
Alnylam Pharmaceuticals Stock Falls After Detailed Vutrisiran Data For A Condition With Stiff Heart Muscles
August 30, 2024
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
From Benzinga
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 10 Years
August 07, 2024
From Benzinga
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
From InvestorPlace
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
August 04, 2024
From Benzinga
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
August 01, 2024
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
From Benzinga
From Benzinga
Alnylam Stock Is a Blockbuster Biopharma In the Making
July 18, 2024
From InvestorPlace
35% Surge Just the Beginning? Alnylam’s Stock Poised for Massive Gains on Heart Drug Success.
July 11, 2024
Tickers
ALNY
From InvestorPlace
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
From InvestorPlace
From Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.